A Netflix Co-Founder on Why This Generation Loves MoviePass
Declining theater traffic doesn’t scare MoviePass.
CEO Mitch Lowe joined Cheddar to discuss why his company’s subscription-based model can bring more moviegoers to the seats.
“Millions of people who’ve grown up with subscriptions love this whole idea of paying one flat-fee and then being able to go when they want, to see whatever they want,” said Lowe, who is also a co-founder of Netflix.
“People really do want to go to the movies more often, and especially young people. What they’ve really been looking for is better way to do it.”
The rise of Netflix and other video-streaming services has led to a drastic decline in movie theater attendance, with the number of tickets sold expected to hit a 22-year low in 2017. According to a survey by research firm Statista, almost a third of respondents say they go out to see a film less than once a year.
But Lowe hopes MoviePass can get people to go out more frequently.
“The people that our price point is attractive to are the people who only spent $40, $50 last year going to the movies, People who went only four or five times,” he said. “When they joined MoviePass now they’re going ten times a year.”.
MoviePass, majority owned by Helios and Matheson, last week announced it hit 1 million subscribers, only 4 months after cutting its monthly fee to under $10 a month.
For full interview [click here](https://cheddar.com/videos/moviepass-hits-1-million-subscriber-mark).
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.
After years of being told that red wine was good for heart health, more Americans appear to be heeding warnings that even moderate alcohol consumption can be unhealthy.
Amazon is now rolling out a service where its Prime members can order their blueberries and milk at the same time as their batteries and other basic items.
Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.
Jessica Inskip, Director of Investor Research at StockBrokers.com and host of MarketMakeHer, unpacks earnings, market outlook, and what history says is next.